{
    "organizations": [],
    "uuid": "82e25d30061d4f7ce9e384615a5d6ceae8995917",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zhejiang-jiuzhou-pharmaceutical-se/brief-zhejiang-jiuzhou-pharmaceutical-sees-fy-2017-net-profit-up-30-pct-to-50-pct-idUSL4N1PH2WY",
    "ord_in_thread": 0,
    "title": "BRIEF-Zhejiang Jiuzhou Pharmaceutical sees FY 2017 net profit up 30 pct to 50 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 22 (Reuters) - Zhejiang Jiuzhou Pharmaceutical Co Ltd\n* Says it sees net profit for FY 2017 to increase by 30 percent to 50 percent\n* Says the net profit of FY 2016 was 111.5 million yuan\n* Comments that increased gross profit rate of CDMO business as well as increased income of API business as main reasons for the forecast\nSource text in Chinese: goo.gl/uuZE1e\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-22T15:52:00.000+02:00",
    "crawled": "2018-01-23T18:07:01.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "zhejiang",
        "jiuzhou",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "see",
        "net",
        "profit",
        "fy",
        "increase",
        "percent",
        "percent",
        "say",
        "net",
        "profit",
        "fy",
        "million",
        "yuan",
        "comment",
        "increased",
        "gross",
        "profit",
        "rate",
        "cdmo",
        "business",
        "well",
        "increased",
        "income",
        "api",
        "business",
        "main",
        "reason",
        "forecast",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}